Transplant; Complication, Rejection Clinical Trial
— INTEGRATEOfficial title:
A Multi-centre, Longitudinal (Cohort) Study in Patients Undergoing Intestinal or Multivisceral Transplantation to Validate Gothenburg Intestinal Transplant Endoscopy Score (GITES) and Evaluate Its Clinical Performance
NCT number | NCT03444675 |
Other study ID # | GBG18001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 29, 2014 |
Est. completion date | May 1, 2023 |
The study validates prospectively a new endoscopic scoring system (Gothenburg Intestinal Transplant Endoscopy Score, GITES) designed to summarize and stratify the abnormal ileal endoscopic findings after intestinal transplantation. GITES is a five-tier, four grade score which asseses mucosal friability, mucosal erythema and mucosal injury (ulcerations) as well as villous changes according to severity. These features (i.e., endoscopic descriptors) are also grouped from mild to very severe in the same sequence as observed during the progression of several pathologic conditions encountered after intestinal transplantation (acute rejection, infectious enteritis).
Status | Recruiting |
Enrollment | 80 |
Est. completion date | May 1, 2023 |
Est. primary completion date | May 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - transplantation of a segment of small intestine (as isolated graft or together with other organs) Exclusion Criteria: - contraindications for ileoscopy |
Country | Name | City | State |
---|---|---|---|
Argentina | Favaloro Foundation University Hospital | Buenos Aires | |
Spain | Hospital Universitario "La Paz" | Madrid | |
Sweden | Sahlgrenska University Hospital | Gothenburg | |
United States | MedStar Georgetown University Hospital | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
Sahlgrenska University Hospital, Sweden | Favaloro Foundation University Hospital, Buenos Aires, Argentina, Hospital Universitario La Paz, MedStar Georgetown University Hospital, Washington DC, Sahlgrenska University Hospital, Gothenburg, Sweden |
United States, Argentina, Spain, Sweden,
Sigurdsson L, Reyes J, Putnam PE, del Rosario JF, Di Lorenzo C, Orenstein SR, Todo S, Kocoshis SA. Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol. 1998 Feb;93(2):207-11. — View Citation
Tabasco-Minguillán J, Weber K, Nelson F, Hutson W, Furukawa H, Abu-Elmagd K, Todo S, Rakela J. Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. Transplant Proc. 1996 Oct;28(5):2775-6. — View Citation
Varkey J, Stotzer PO, Simrén M, Herlenius G, Oltean M. The endoscopic surveillance of the transplanted small intestine: a single center experience and a proposal for a grading score. Scand J Gastroenterol. 2018 Feb;53(2):134-139. doi: 10.1080/00365521.2017.1411523. Epub 2017 Dec 12. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Endoscopic evaluation | To validate the GITES grading system in intestinal graft recipients using high-definition white light endoscopy | 7 years | |
Secondary | Correlations with histology and Clinical course | Comparison and correlation of clinical and histopathological data with endoscopic findings to evaluate the conditions leading to the mucosal alterations defined by established endoscopic descriptors and GITES. | 1 year | |
Secondary | Performance of the grading score | Endpoints include sensitivity, specificity, positive predictive value, negative predictive value as well as inter- and intraobserver variation in the evaluation of the mucosal alterations by means of GITES and using high-definition white light endoscopy; | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04496037 -
Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant
|
||
Completed |
NCT01354301 -
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
|
Phase 4 | |
Recruiting |
NCT03172091 -
Volatile Organic Compounds as Markers of Acute Rejection in Lung Transplant
|
N/A | |
Completed |
NCT04019353 -
Cf-DNA Assay During Treatment of Acute Rejection
|
||
Recruiting |
NCT04855422 -
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
|
||
Recruiting |
NCT03422224 -
ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation
|
||
Active, not recruiting |
NCT03882164 -
Blood-Bile Ratio Tacrolimus After Liver Transplantation
|
||
Not yet recruiting |
NCT05951231 -
Liver Transplantation After ex Vivo Liver Perfusion
|
N/A | |
Enrolling by invitation |
NCT04234139 -
Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation
|